Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-03-02 @ 6:24 PM
Study NCT ID:
NCT02506933
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-22
First Post:
2015-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
Sponsor:
City of Hope Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Acute Lymphoblastic Leukemia in Remission | View |
| None | Acute Myeloid Leukemia in Remission | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Cytomegaloviral Infection | View |
| None | Hodgkin Lymphoma | View |
| None | Lymphadenopathy | View |
| None | Lymphoblastic Lymphoma | View |
| None | Myelodysplastic Syndrome | View |
| None | Myelofibrosis | View |
| None | Myeloproliferative Neoplasm | View |
| None | Non-Hodgkin Lymphoma | View |
Keywords: